Thrivent Financial for Lutherans’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$23.6M Buy
2022
Q4
$22.1M Buy
2022
Q3
$17.2M Buy
2022
Q2
$14.4M Buy
2022
Q1
$15.6M Buy
2021
Q4
$14.4M Buy
2020
Q4
Sell
2020
Q3
$9.85M Hold
2020
Q2
$9.21M Buy